Previous studies also reported that MCM3 hypomethylation could increase its expression in hepatocellular carcinoma (Hua et al., 2020) and osteosarcoma (Zhou et al., 2021), and was negatively associated with prognosis. Here, MCM3 is linked to hepatocellular carcinoma.